• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic?1例新型冠状病毒肺炎患者在使用奥司他韦和羟氯喹后银屑病加重：新型冠状病毒肺炎大流行后银屑病病例会增加吗？
Dermatol Ther. 2020 Jul;33(4):e13383. doi: 10.1111/dth.13383. Epub 2020 Apr 24.
2
Hydroxychloroquine effects on psoriasis: A systematic review and a cautionary note for COVID-19 treatment.羟氯喹对银屑病的作用：系统评价及对 COVID-19 治疗的警示。
J Am Acad Dermatol. 2020 Aug;83(2):579-586. doi: 10.1016/j.jaad.2020.05.074. Epub 2020 May 19.
3
Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19.氯喹和羟氯喹用于治疗新型冠状病毒肺炎的安全性考量
Clin Microbiol Infect. 2020 Sep;26(9):1276-1277. doi: 10.1016/j.cmi.2020.05.006. Epub 2020 May 16.
4
COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern?新型冠状病毒肺炎与氯喹/羟氯喹：是否存在眼科方面的问题？
Am J Ophthalmol. 2020 May;213:A3-A4. doi: 10.1016/j.ajo.2020.03.028. Epub 2020 Mar 25.
5
Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.阿奇霉素和羟氯喹对新冠肺炎住院患者的前瞻性预防（ProPAC-COVID）：一项随机对照试验研究方案的结构化总结
Trials. 2020 Jun 10;21(1):513. doi: 10.1186/s13063-020-04409-9.
6
Covid-19 and exacerbation of psoriasis.新冠病毒-19与银屑病病情加重
Dermatol Ther. 2020 Jul;33(4):e13632. doi: 10.1111/dth.13632. Epub 2020 Jun 2.
7
Hydroxychloroquine-induced erythema multiforme in a patient with COVID-19.新冠病毒病患者中羟氯喹诱发的多形红斑
Med Clin (Barc). 2020 Sep 11;155(5):231. doi: 10.1016/j.medcli.2020.05.004. Epub 2020 May 19.
8
Hydroxychloroquine in the treatment of COVID-19: How to use it waiting for conclusive scientific evidence.羟氯喹治疗新型冠状病毒肺炎：在等待确凿科学证据期间如何使用
Med Clin (Barc). 2020 Aug 14;155(3):134-135. doi: 10.1016/j.medcli.2020.05.006. Epub 2020 May 16.
9
Chloroquine and hydroxychloroquine during pregnancy: What do we know?孕期使用氯喹和羟氯喹：我们了解些什么？
Therapie. 2020 Jul-Aug;75(4):384-385. doi: 10.1016/j.therap.2020.05.004. Epub 2020 May 11.
10
Chloroquine and hydroxychloroquine in covid-19.氯喹和羟氯喹在2019冠状病毒病中的应用
BMJ. 2020 Apr 8;369:m1432. doi: 10.1136/bmj.m1432.

引用本文的文献

1
Erythrodermic Psoriasis in the Context of Emerging Triggers: Insights into Dupilumab-Associated and COVID-19-Induced Psoriatic Disease.新发触发因素背景下的红皮病型银屑病：度普利尤单抗相关及新冠病毒诱导的银屑病性疾病解析
Dermatopathology (Basel). 2025 Jun 9;12(2):17. doi: 10.3390/dermatopathology12020017.
2
Clinical characteristics and outcomes of psoriasis patients with COVID-19: A retrospective, multicenter cohort study in China.中国一项回顾性、多中心队列研究：COVID-19 患者的银屑病临床特征和结局。
Chin Med J (Engl). 2024 Jul 20;137(14):1736-1743. doi: 10.1097/CM9.0000000000003024. Epub 2024 May 6.
3
Triggers for the onset and recurrence of psoriasis: a review and update.触发银屑病发病和复发的因素：综述与更新。
Cell Commun Signal. 2024 Feb 12;22(1):108. doi: 10.1186/s12964-023-01381-0.
4
The Psoriasis Disability Index in Romanian Psoriasis Patients during COVID-19 Pandemic: Contribution of Clinical and Psychological Variables.新冠疫情期间罗马尼亚银屑病患者的银屑病残疾指数：临床和心理变量的作用
J Clin Med. 2023 Sep 16;12(18):6000. doi: 10.3390/jcm12186000.
5
Efficacy of drug regimen with and without oseltamivir in hospitalized patients with COVID-19: A retrospective study.新冠病毒肺炎住院患者使用与不使用奥司他韦药物治疗方案的疗效：一项回顾性研究
Vacunas. 2023 Apr-Jun;24(2):141-149. doi: 10.1016/j.vacun.2022.09.077. Epub 2022 Oct 4.
6
Examination of Cutaneous Changes Among Patients Following SARS-CoV-2 Infection.新型冠状病毒感染患者皮肤变化的检查
Cureus. 2022 Jul 20;14(7):e27052. doi: 10.7759/cureus.27052. eCollection 2022 Jul.
7
Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic Review.新型冠状病毒肺炎患者与非新型冠状病毒肺炎患者短期口服氯喹和羟氯喹治疗的安全性：一项系统评价
Pharmaceuticals (Basel). 2022 May 21;15(5):634. doi: 10.3390/ph15050634.
8
Erythrodermic psoriasis in post-coronavirus disease 2019 patient.新型冠状病毒肺炎患者的红皮病型银屑病
Asia Pac Allergy. 2022 Apr 21;12(2):e16. doi: 10.5415/apallergy.2022.12.e16. eCollection 2022 Apr.
9
First-Trimester Impetigo Herpetiformis Leads to Stillbirth: A Case Report.孕早期疱疹样脓疱病导致死产：一例报告
Dermatol Ther (Heidelb). 2022 May;12(5):1271-1279. doi: 10.1007/s13555-022-00735-9. Epub 2022 May 2.
10
Exacerbation of Psoriasis Following COVID-19 Vaccination: Report From a Single Center.新型冠状病毒肺炎疫苗接种后银屑病病情加重：来自单一中心的报告
Front Med (Lausanne). 2021 Dec 23;8:812010. doi: 10.3389/fmed.2021.812010. eCollection 2021.

本文引用的文献

1
Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.在大流行期间治疗新冠病毒病——超说明书用药、同情用药及随机临床试验
JAMA. 2020 May 19;323(19):1897-1898. doi: 10.1001/jama.2020.4742.
2
COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action.新型冠状病毒肺炎与银屑病：是时候限制免疫抑制剂的使用了吗？呼吁采取行动。
Dermatol Ther. 2020 Jul;33(4):e13298. doi: 10.1111/dth.13298. Epub 2020 Mar 22.
3
Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools.理解 SARS-CoV-2 介导的炎症反应：从机制到潜在的治疗工具。
Virol Sin. 2020 Jun;35(3):266-271. doi: 10.1007/s12250-020-00207-4. Epub 2020 Mar 3.
4
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病（COVID-19）疫情的特征及重要经验教训：来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
5
The COVID-19 epidemic.新冠疫情。
Trop Med Int Health. 2020 Mar;25(3):278-280. doi: 10.1111/tmi.13383. Epub 2020 Feb 16.
6
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
7
Chloroquine promotes IL-17 production by CD4+ T cells via p38-dependent IL-23 release by monocyte-derived Langerhans-like cells.氯喹通过单核细胞衍生的朗格汉斯样细胞释放依赖p38的白细胞介素-23，促进CD4 + T细胞产生白细胞介素-17。
J Immunol. 2014 Dec 15;193(12):6135-43. doi: 10.4049/jimmunol.1303276. Epub 2014 Nov 10.
8
The in vitro effect of hydroxychloroquine on skin morphology in psoriasis.羟氯喹对银屑病皮肤形态的体外作用。
Int J Dermatol. 1999 Feb;38(2):154-7. doi: 10.1046/j.1365-4362.1999.00574.x.

A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic?

作者信息

Kutlu Ömer, Metin Ahmet

机构信息

Department of Dermatology and Venereology, School of Medicine, Uşak University, Uşak, Turkey.

出版信息

Dermatol Ther. 2020 Jul;33(4):e13383. doi: 10.1111/dth.13383. Epub 2020 Apr 24.

DOI:10.1111/dth.13383
PMID:32259878
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7235511/
Abstract
摘要